Aquestive Therapeutics Inc. (AQST) Tops Q2 EPS by 9c

Aquestive Therapeutics Inc. (NASDAQ: AQST) reported Q2 EPS of ($0.03), $0.09 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $20.09 million versus the consensus estimate of $12.45 million.

For earnings history and earnings-related data on Aquestive Therapeutics Inc. (AQST) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• XORTX to voluntarily delist from TSX Venture Exchange
• Lockheed Martin wins $2.8B in Defense contracts for F-35, helicopters